top of page
Investors
Our Journey
May 2015
Company founded in Malaysia​
July 2015
Successfully awarded seed grant of USD150,000 by Malaysian government agency, Platcom Ventures
August 2015
Selected by Malaysia Global Innovation & Creativity Centre (MaGIC) for e@Stanford USA Program Batch 2015
November 2018
Launching of biosensor platform for molecular diagnostics
May 2019
Launching of in silico platform for design and validation of oligo-based synthetic antibodies (aptamers)
July 2019
Participated in NextRise 2019 Korea for pitching to regional investors
For more detailed information, please email contact@biogenestech.com
bottom of page